Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Insight of N6-Methyladenosine in Cardiovascular System. | Medicina (Kaunas) | 2025 | 40005339 | PubTator, text mining | PubMed |
| The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases. | Biomolecules | 2025 | 40001550 | PubTator, text mining | PubMed |
| M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms. | Biomolecules | 2025 | 40001461 | PubTator, text mining | PubMed |
| Identification of a novel signature based on RNA methylation-associated anoikis-related genes for predicting prognosis and characterizing immune landscape in colorectal cancer. | Discov Oncol | 2025 | 40000539 | PubTator, text mining | PubMed |
| Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers. | Mol Ther Nucleic Acids | 2025 | 39995977 | PubTator, text mining | PubMed |
| m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas. | BMC Med Genomics | 2025 | 39994800 | PubTator, text mining | PubMed |
| FTO-induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN-mediated lipid metabolism. | Int J Biol Sci | 2025 | 39990672 | PubTator, text mining | PubMed |
| USP14 modulates stem-like properties, tumorigenicity, and radiotherapy resistance in glioblastoma stem cells through stabilization of MST4-phosphorylated ALKBH5. | Theranostics | 2025 | 39990235 | PubTator, text mining | PubMed |
| Integration of 101 machine learning algorithm combinations to unveil m6A/m1A/m5C/m7G-associated prognostic signature in colorectal cancer. | Sci Rep | 2025 | 39966486 | PubTator, text mining | PubMed |
| Mechanisms of GPM6A in Malignant Tumors. | Cancer Rep (Hoboken) | 2025 | 39957375 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis of ENOPH1 in human tumors. | Discov Oncol | 2025 | 39955431 | PubTator, text mining | PubMed |
| METTL14 suppresses the migration and invasion of hepatocellular carcinoma cells by m6A methylation of RPLP2. | Sci Rep | 2025 | 39955344 | PubTator, text mining | PubMed |
| Non-synonymous single nucleotide polymorphisms (nsSNPs) within the extracellular domains of the GPM6A gene impair hippocampal neuron development. | Biochim Biophys Acta Mol Cell Res | 2025 | 39938689 | PubTator, text mining | PubMed |
| Discovery of a Novel Selective and Cell-Active N6-Methyladenosine RNA Demethylase ALKBH5 Inhibitor. | J Med Chem | 2025 | 39925002 | PubTator, text mining | PubMed |
| Discovery of maleimide derivatives as m6A demethylase ALKBH5 inhibitors. | Bioorg Med Chem | 2025 | 39904196 | PubTator, text mining | PubMed |
| Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway. | Oncogene | 2025 | 39900725 | PubTator, text mining | PubMed |
| Betaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM/m6A/YTHDF1-mediated enhancement on ATG3 stability. | Theranostics | 2025 | 39897540 | PubTator, text mining | PubMed |
| Construction of a hierarchical DNA circuit for single-molecule profiling of locus-specific N6-methyladenosine-MALAT1 in clinical tissues. | Biosens Bioelectron | 2025 | 39893948 | PubTator, text mining | PubMed |
| ALKBH5 alleviates lower extremity arteriosclerosis by regulating ITGB1 demethylation and influencing macrophage polarization. | Heliyon | 2025 | 39866442 | PubTator, text mining | PubMed |
| m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A/Npas2/Hif-1α axis. | FASEB J | 2025 | 39831513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=6